This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Merck & Co. Inc. slipped 2.9% to $87.12 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.4% to 5,633.07 and the Dow Jones Industrial Average falling 0.0% to 41,989.96.
The stock's fall snapped a two-day winning streak.
Merck & Co. Inc. closed 35.3% below its 52-week high of $134.63, which the company reached on June 25th.
The stock demonstrated a mixed performance when compared to some of its competitors, as Johnson & Johnson fell 7.6% to $153.25, Pfizer Inc. fell 3.2% to $24.54, and Eli Lilly & Co. fell 2.50% to $805.23.
Trading volume totaled 13.9 million, compared to the 50-day average of 17.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 01, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。